Mycobacterium tuberculosis caseinolytic protease ClpP1P2 complex (ClpP1P2)

The Mycobacterium tuberculosis caseinolytic protease ClpP1P2 complex is a heterotetradecameric serine protease essential for the survival and virulence of the tuberculosis pathogen (Raju et al., 2012). It consists of two distinct heptameric rings, ClpP1 and ClpP2, which must associate to form a functional proteolytic chamber (Schmitz et al., 2014). This complex works in conjunction with AAA+ ATPases like ClpC1 and ClpX, which recognize, unfold, and translocate substrate proteins into the ClpP1P2 chamber for degradation (Taylor et al., 2022). Unlike most bacterial ClpP systems, the Mtb ClpP1P2 complex is unique in its heteromeric structure and its absolute requirement for bacterial viability in both growing and dormant states (Akopian et al., 2012). As a validated drug target, ClpP1P2 can be modulated by two primary pharmacological strategies: direct inhibition of its catalytic activity or dysregulation through over-activation (Moreira et al., 2015). Direct inhibitors, such as peptide boronates and bortezomib, block the active sites to prevent the degradation of essential proteins and the clearance of toxic misfolded ones (Schmitz et al., 2014). Conversely, activators like acyldepsipeptides (ADEPs) can trigger "rogue" proteolysis, causing the enzyme to degrade non-target cellular proteins indiscriminately (Brotz-Oesterhelt et al., 2005). Given its critical role in maintaining proteostasis and its structural divergence from human proteases, the ClpP1P2 complex represents a promising avenue for developing novel antitubercular agents to combat multidrug-resistant strains (TB Alliance, 2025). Its structural differences from human proteases provide a therapeutic window, although potential cross-reactivity with human mitochondrial ClpP remains a consideration in drug design (Schmitz et al., 2014).

Other names

ClpP1P2 proteaseMtb ClpP1P2Caseinolytic peptidase P1P2 complexClpP1/P2 complexHeteromeric ClpP1P2 complex

Inhibition of proteolytic activity; Over-activation of proteolysis (rogue proteolysis); Uncoupling of ATPase and peptidase activities